Logo image
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma
Journal article   Open access   Peer reviewed

The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma

Natalie K. Heater, Scott Okuno, Steven Robinson, Steven Attia, Mahesh Seetharam, Brittany L. Siontis, Janet Yoon, Sant Chawla, Mohammed M. Milhem, Varun Monga, …
Journal of clinical medicine, Vol.12(7), 2561
03/29/2023
DOI: 10.3390/jcm12072561
PMCID: PMC10095464
PMID: 37048645
url
https://doi.org/10.3390/jcm12072561View
Published (Version of record) Open Access

Abstract

The treatment of sarcoma necessitates a collaborative approach, given its rarity and complex management. At a single institution, multidisciplinary teams of specialists determine and execute treatment plans involving surgical, radiation, and medical management. Treatment guidelines for systemic therapies in advanced or nonresectable soft tissue sarcoma have advanced in recent years as new immunotherapies and targeted therapies become available. Collaboration between institutions is necessary to facilitate accrual to clinical trials. Here, we describe the success of the Midwest Sarcoma Trials Partnership (MWSTP) in creating a network encompassing large academic centers and local community sites. We propose a new model utilizing online platforms to expand the reach of clinical expertise for the treatment of advanced soft tissue sarcoma.
advanced soft tissue sarcoma Brief Report collaboration Midwest Sarcoma Trials Partnership multidisciplinary tumor board sarcoma treatment targeted therapy

Details

Metrics

Logo image